Search by tag «Medicine» 103 results

• ITMO Presents Medical Diagnostics and Genetic Analysis Solutions at Bioprom Forum

  The international forum Bioprom: Industry and Technology For Humans has recently concluded in the city of Gelendzhik. At the event, ITMO showcased its biotechnology contributions: from approaches to specialist training to development of new technologies and startups. Learn more in this ITMO NEWS story.

  09.10.2026

• ITMO’s Monday Science Roundup #114

  Medical research, AI in the workplace, and surprising applications for MRI: more on these and other topics in today’s digest of science news from ITMO University.

  05.10.2026

• 2026 Nobel Prize in Physiology and Medicine: Controlling Brain With Light

  This year’s Nobel Prize in Physiology and Medicine is going to Karl Deisseroth, Peter Hegemann, and Georg Nagel, whose research helped shed light on how our multibillion-cell brain forms memories, feelings, and behavior strategies. The scientists’ achievements laid the foundation for optogenetics, a method of studying neurons. Why did they receive the Nobel Prize? How does optogenetics help treat diseases? And who studies the brain at ITMO? That’s what we discussed with Vera Medvedeva, a senior researcher at ITMO’s Center for Molecular and Biological Technologies, and Evgeniya Sokolova, the head of the Public Health Sciences Master’s program.

  05.10.2026

• ITMO Scientists Develop New Ultrasensitive Sensor Design for Medical Diagnostics That Outperforms Counterparts

  Researchers from ITMO in collaboration with colleagues from Russia and China have suggested a new design for an ultrasensitive terahertz sensor that contains radiation inside the structure and amplifies its interaction with the analyzed substance. According to calculations, such a system will be capable of highly accurately observing changes in the composition of liquid media without the use of chemical reagents. In the future, the solution can be used in medical diagnostics, environmental monitoring, and industrial quality control. The results of the Russian Science Foundation-supported study are published in Nanophotonics.

  09.09.2026

• ITMO To Receive 180 Million Rubles for High-Tech Optical Equipment

  ITMO University was selected by the Russian Ministry of Science and Higher Education to receive a subsidy of 180 million rubles to encourage domestic engineering production. The funding will be used to build a spectrophotometer – a device that measures the amount of light absorbed by a liquid sample to identify its composition and proportions. The technology will make it possible to determine substances present in a single drop of solution, verify the quality of medications, and analyze biological samples. The university will receive the allocated funding in 2026-2028.

  25.08.2026

• ITMO’s Monday Science Roundup #104

  As always, nothing stands still at ITMO. While some researchers make strides in medical technology, others develop next-gen software. And that’s not to mention the artistic and academic achievements of graduates and current students! All this and more – in our bi-weekly summary of science news from ITMO University.

  18.05.2026

• ITMO Researchers Find New Molecular Target for Popular Cancer Treatment

  Scientists from ITMO University are the first in the world to find a new mechanism for irinotecan, a known cancer treatment. Earlier, it was known to interact with only one protein that regulates DNA structure and is connected to cancer development. Using molecular modeling methods, ITMO chemists have discovered that irinotecan can block the activity of another protein, A2B1, that is connected to colorectal, lung, and other types of cancer. The paper opens up possibilities for development of more efficient targeted cancer treatments with fewer side effects. The results of the Russian Science Foundation-supported study have been published in Journal of Chemical Information and Modeling.

  01.04.2026

• Immune System Researchers Receive Nobel Prize in Physiology or Medicine: Why It Matters

  The 2025 Nobel Prize in Physiology or Medicine has been awarded to Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi for their research into immune tolerance. What is the importance of their work? How did they help us redefine the immunology paradigm? And what new avenues have they unlocked towards treatment of dangerous diseases? We dig into these questions with Oleg Kuchur, a senior researcher at ITMO’s Center for Molecular and Biological Technologies.

  07.10.2025

• GEROPHARM and ITMO Test New Treatment for Blood Disease

  Public health scientists from ITMO, in collaboration with the biotech company GEROPHARM and other Russian colleagues, have recently completed the third testing stage of a new medicine for patients with immune thrombocytopenia. In this condition, the body mistakenly destroys its own thrombocytes. The new treatment is described in a paper published in eJHaem.

  22.08.2025

• ITMO’s Monday Science Roundup #79

  From AI-driven solutions to chemical breakthroughs, here are ITMO’s top scientific highlights of the recent weeks.

  19.05.2025